Health & Science
Video A Place for Mom CEO Tatyana Zlotsky: Solving America’s growing caregiving crisis
An immigrant who rebuilt her life from nothing now helps families rebuild theirs, one 20-minute phone call at a time.
Video Mochi Founder & CEO Dr. Myra Ahmad: How GLP-1s are transforming healthcare
A physician-founder on marketplaces, regulators, cardboard boxes, and the argument she has to win.
Video Honor Technology CEO, Seth Sternberg: Why technology should be “world good”
Honor Technology CEO Seth Sternberg discusses the upcoming aging crisis, how AI is transforming eldercare, and why tech founders must prioritize real-world impact over valuations.
Video Ansel Health CEO Veer Gidwaney: The startup tackling America's $88 billion medical debt problem
The founder and CEO of Ansel Health on medical debt, killing projects, and the two-page document every new hire receives.
Blog The case for slashing drug prices
The United States, with less than five percent of the global population, accounts for roughly three-quarters of worldwide pharmaceutical profits.
Blog The efficacy of GLP-1 drugs
A quiet revolution is reshaping the contours of American medicine, and it comes in the form of a weekly injection.
Video SonarMD CEO Beth Houck: Patient data and analytics
SonarMD's CEO on the coach who asked when she'd stop, the comment that took the air out of her head, and the disease nobody cures.
Video Pluri CEO Yaky Yanay: The biotech company based in Israel
Twenty years, $461 million in accumulated losses, and a man who still wakes at 5 a.m. certain he's right.
Video Samsara Vision CEO Thomas Ruggia
Samsara Vision CEO Thomas Ruggia on restoring central vision to patients who were told nothing more could be done.
Video Lumary CEO Joe Mercorella
Lumary's CEO built a healthcare software business in a city with no venture capital, no playbook, and partners who told him not to bother.
Video Calibrate Health CEO Rob MacNaughton
On coaching, remote work, and why the weight comes back when the prescription stops.
Video Insmed CEO Will Lewis
A former CIA officer and investment banker on why drug development takes so long, and why he thinks it shouldn't.